T2 Biosystems Inc

General ticker "TTOO" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $8.3M

T2 Biosystems Inc does not follow the US Stock Market performance with the rate: -30.5%.

Estimated limits based on current volatility of 6.3%: low 0.31$, high 0.35$

Factors to consider:

  • Current price 88.7% below estimated low
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [3.16$, 15.59$]
  • 2024-12-30 to 2025-12-30 estimated range: [1.68$, 7.22$]

Financial Metrics affecting the TTOO estimates:

  • Negative: Non-GAAP EPS, $ of -131.90 <= 0.10
  • Negative: Operating profit margin, % of -87.35 <= 1.03
  • Negative: Operating cash flow per share per price, % of -81.95 <= 2.35
  • Negative: negative Net income
  • Negative: Inventory ratio change, % of 23.21 > 1.08

Similar symbols

Short-term TTOO quotes

Long-term TTOO plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $28.06MM $22.30MM $7.19MM
Operating Expenses $71.03MM $77.50MM $56.86MM
Operating Income $-42.97MM $-55.20MM $-49.66MM
Non-Operating Income $-6.27MM $-7.46MM $-0.41MM
Interest Expense $6.59MM $6.08MM $5.34MM
R&D Expense $21.80MM $25.93MM $14.15MM
Income(Loss) $-49.24MM $-62.66MM $-50.08MM
Profit(Loss) $-49.24MM $-62.66MM $-50.08MM
Stockholders Equity $-12.90MM $-39.66MM $-28.04MM
Inventory $3.91MM $4.35MM $4.82MM
Assets $60.54MM $34.33MM $34.80MM
Operating Cash Flow $-38.87MM $-50.63MM $-48.14MM
Capital expenditure $0.46MM $0.34MM $0.19MM
Investing Cash Flow $24.79MM $9.66MM $-0.19MM
Financing Cash Flow $20.54MM $29.05MM $52.69MM
Earnings Per Share* $-1,683.72 $-1,242.48 $-19.19

* EPS are Split Adjusted, recent splits may be reflected with a delay.